Celldex Therapeutics (CLDX) earnings, Aug 6, 2026: EPS −11%, stock +0.4%
In brief
Celldex Therapeutics reported on Aug 6, 2026. Earnings per share changed −11% year over year, 11.0% above the estimate; revenue −97%. The stock opened with a +0.7% gap and closed the day +0.4% (Aug 7, 2026). The stock is now 37.4% below its 52-week high, +19.1% over 12 months. Next report: Nov 11, 2026.
EPS vs estimate+11.0%
EPS, YoY−11%
Revenue, YoY−97%
Gap · day+0.7% · +0.4%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 6, 2026 | +0.7% | +0.4% |
Next-quarter estimates, ratings and the CLDX chart are in the terminal.
Open the terminalFAQ
When is Celldex Therapeutics's next earnings report?
Nov 11, 2026. The date comes from daily data and is corrected if the company moves it.
How did Celldex Therapeutics stock react to the report?
Opening gap +0.7%, day's result +0.4%.
Did Celldex Therapeutics's earnings grow?
Earnings per share fell 11% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.